Definitive Healthcare Corp. (NASDAQ:DH) Receives $5.81 Consensus PT from Analysts

Definitive Healthcare Corp. (NASDAQ:DH) has been given an average recommendation of “Hold” by the eleven ratings firms that are presently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the company. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is $5.81.

A number of research analysts have recently issued reports on the stock. Barclays cut their price objective on shares of Definitive Healthcare from $6.00 to $4.00 and set an “equal weight” rating on the stock in a research report on Wednesday, August 7th. Deutsche Bank Aktiengesellschaft reduced their price target on Definitive Healthcare from $7.00 to $5.00 and set a “hold” rating on the stock in a research report on Friday, August 9th. JPMorgan Chase & Co. cut Definitive Healthcare from a “neutral” rating to an “underweight” rating and lowered their price objective for the stock from $7.00 to $5.00 in a research report on Wednesday, July 31st. Morgan Stanley reduced their target price on Definitive Healthcare from $9.00 to $5.00 and set an “equal weight” rating on the stock in a research report on Tuesday, August 6th. Finally, BTIG Research initiated coverage on Definitive Healthcare in a report on Tuesday, September 17th. They issued a “buy” rating and a $7.00 price target for the company.

Definitive Healthcare Stock Performance

Definitive Healthcare stock opened at $4.47 on Tuesday. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.40 and a quick ratio of 2.40. The firm has a market capitalization of $527.17 million, a P/E ratio of -2.55, a price-to-earnings-growth ratio of 6.27 and a beta of 1.33. Definitive Healthcare has a 1-year low of $3.19 and a 1-year high of $10.62. The company’s 50-day moving average is $4.35 and its 200 day moving average is $5.38.

Definitive Healthcare (NASDAQ:DH) last announced its quarterly earnings data on Monday, August 5th. The company reported $0.09 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.09. The company had revenue of $63.70 million during the quarter, compared to analyst estimates of $63.19 million. Definitive Healthcare had a negative net margin of 156.65% and a positive return on equity of 0.98%. The firm’s revenue for the quarter was up 4.4% on a year-over-year basis. During the same quarter last year, the business posted $0.08 EPS. Research analysts forecast that Definitive Healthcare will post 0.07 EPS for the current year.

Hedge Funds Weigh In On Definitive Healthcare

Several hedge funds and other institutional investors have recently modified their holdings of the business. Swiss National Bank lifted its position in Definitive Healthcare by 2.9% during the first quarter. Swiss National Bank now owns 103,300 shares of the company’s stock worth $834,000 after buying an additional 2,900 shares in the last quarter. The Manufacturers Life Insurance Company boosted its position in shares of Definitive Healthcare by 17.0% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 22,896 shares of the company’s stock valued at $125,000 after acquiring an additional 3,332 shares during the last quarter. Principal Financial Group Inc. grew its holdings in shares of Definitive Healthcare by 10.8% in the second quarter. Principal Financial Group Inc. now owns 39,856 shares of the company’s stock valued at $218,000 after purchasing an additional 3,874 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank increased its position in Definitive Healthcare by 31.4% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 21,292 shares of the company’s stock worth $116,000 after purchasing an additional 5,083 shares during the last quarter. Finally, Valeo Financial Advisors LLC raised its stake in Definitive Healthcare by 11.8% during the second quarter. Valeo Financial Advisors LLC now owns 59,080 shares of the company’s stock worth $323,000 after purchasing an additional 6,230 shares during the period. 98.67% of the stock is owned by hedge funds and other institutional investors.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.